CD8A and neoplasm: This blockade of the PD-1/PD-L1 axis restored CD8 + T cell function, as evidenced by increased proliferation and elevated secretion of IFN-γ and IL-2, contributing to tumor regression and TME remodeling (Zhu et al., 2025).